Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment

Eur Psychiatry. 2004 Sep;19(6):382-3. doi: 10.1016/j.eurpsy.2004.06.021.

Abstract

In a double blind controlled study, rTMS results in a similar antidepressant effect to sham in combination with paroxetine. Both groups had the same delay in scale's scores improvement. rTMS seems not to be efficient as an add-on treatment to pharmacological medication in non-resistant major depression.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / therapy*
  • Double-Blind Method
  • Humans
  • Paroxetine / therapeutic use*
  • Periodicity*
  • Skull
  • Surveys and Questionnaires
  • Transcranial Magnetic Stimulation / instrumentation*

Substances

  • Antidepressive Agents, Second-Generation
  • Paroxetine